\!DOCTYPE html>
Sources & uses, goodwill calculation, pro forma EPS, and synergy modeling. A complete walkthrough of the IB deal model using a real industrial acquisition scenario.
A merger model is the quantitative backbone of an M&A advisory engagement. It answers two fundamental questions: (1) what does the deal cost and how is it funded, and (2) what happens to the combined company's financials after close? We will walk through every major section using a realistic industrial acquisition.
| Entity | Acquirer | Target |
|---|---|---|
| Revenue | $5,000M | $1,500M |
| EBITDA | $800M | $200M |
| EBITDA Margin | 16.0% | 13.3% |
| Enterprise Value | $10,000M | $2,400M (acquisition price) |
| EV / EBITDA Multiple | 12.5x | 12.0x (entry) |
| Net Debt (at close) | $2,500M | $300M (refinanced) |
| Equity Value | $7,500M | N/A (acquired) |
| Diluted Shares | 250M | N/A (100% cash deal) |
| Stock Price | $40.00 | N/A |
The acquirer is paying 12.0x EBITDA for the target — in line with the acquirer's own trading multiple of 12.5x, suggesting this is a strategic acquisition at a fair price, not a distressed purchase or a stretched premium deal. The target's $300M of existing debt must be refinanced at close (standard in most acquisitions).
| Uses of Funds | Amount | Notes |
|---|---|---|
| Purchase Price (Equity) | $2,400M | 12.0x × $200M EBITDA |
| Refinance Target Net Debt | $300M | Existing target debt repaid at close |
| Transaction Fees & Expenses | $60M | Banker fees, legal, accounting (~2% of deal) |
| Total Uses | $2,760M |
| Sources of Funds | Amount | Notes |
|---|---|---|
| New Term Loan B | $1,000M | 7-year floating rate, L+300 |
| New Senior Notes (Fixed) | $1,222M | 8-year fixed, 6.5% coupon |
| Cash from Balance Sheet | $400M | Acquirer uses existing cash |
| Acquirer Stock (5% consideration) | $138M | 3.45M new shares @ $40 |
| Total Sources | $2,760M | Balances to total uses |
The deal is primarily debt-financed ($2,222M of new debt on top of the acquirer's existing $2,500M), which is typical for an investment-grade industrial acquirer with stable cash flows. The 5% stock component gives target management a small equity stake in the combined company — a common retention mechanism.
Interviewers frequently ask why transaction fees are included in Uses. The answer: fees are a real cash outflow that must be funded, just like the purchase price. Similarly, rolling over target debt (rather than assuming it) is common when debt indentures have change-of-control provisions that require repayment on acquisition.
| Item | Book Value | Fair Value Adjustment | Fair Value |
|---|---|---|---|
| Cash & Working Capital | $120M | — | $120M |
| PP&E | $380M | +$150M | $530M |
| Identified Intangibles | $0 | +$200M | $200M |
| Other Assets | $50M | — | $50M |
| Total Liabilities Assumed | ($300M) | — | ($300M) |
| Fair Value of Net Identifiable Assets | $250M | +$350M | $600M |
| Purchase Price | — | — | $2,400M |
| Goodwill | — | — | $1,800M |
The $1,800M of goodwill goes on the acquirer's balance sheet and is NOT amortized under US GAAP (ASC 350 — Intangibles). Instead, it is tested annually for impairment. If the acquisition underperforms, goodwill impairment charges can be large and are non-cash but hit the income statement.
The $150M PP&E step-up and $200M of identified intangibles DO create incremental D&A. The intangibles are typically amortized over 5–15 years; PP&E step-up is depreciated over the remaining useful life of the assets. This is an important income statement impact.
| Synergy Category | Year 1 | Year 2 | Year 3 | Notes |
|---|---|---|---|---|
| Cost — Headcount Reduction | $40M | $80M | $100M | Overlap in G&A, back-office |
| Cost — Procurement Savings | $15M | $25M | $30M | Combined purchasing power |
| Cost — Facility Consolidation | $5M | $15M | $25M | Plant closures, lease exits |
| Revenue Synergies (cross-sell) | $0 | $30M | $75M | New product in combined channels |
| Total Pre-Tax Synergies | $60M | $150M | $230M | |
| After-Tax (@ 25%) | $45M | $112.5M | $172.5M |
| Integration Costs (One-Time) | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Severance & Employee Costs | $70M | $30M | $10M |
| System Integration / IT | $20M | $20M | $10M |
| Facility Closure Costs | $5M | $5M | $10M |
| Total Integration Costs | $95M | $55M | $30M |
Revenue synergies are kept at zero in Year 1 because they require sales team integration, training, and pipeline development. Conservative analysts often haircut revenue synergies by 50% because they are highly uncertain. Cost synergies, by contrast, are often given more credit because headcount and facility decisions are largely under management control.
| Line Item | Acquirer | Target | Adjustments | Pro Forma |
|---|---|---|---|---|
| Revenue | $5,000 | $1,500 | — | $6,500 |
| EBITDA | $800 | $200 | +$60 | $1,060 |
| Legacy D&A | ($220) | ($60) | — | ($280) |
| Incremental D&A (step-up) | — | — | ($35) | ($35) |
| EBIT | $580 | $140 | +$25 | $745 |
| Legacy Interest Expense | ($125) | ($18) | — | ($143) |
| Incremental Interest (new debt) | — | — | ($155) | ($155) |
| Integration Costs (one-time) | — | — | ($95) | ($95) |
| Pre-Tax Income | $455 | $122 | ($225) | $352 |
| Income Tax (25%) | ($114) | ($31) | +$56 | ($88) |
| Net Income | $341 | $92 | ($169) | $264 |
| EPS Calculation | Standalone | Pro Forma |
|---|---|---|
| Net Income | $341M | $264M |
| Diluted Shares | 250.0M | 253.45M |
| EPS | $1.364 | $1.042 |
| Accretion / (Dilution) | — | (23.6%) |
Year 1 is substantially dilutive — driven by $155M of incremental interest expense on the new debt and $95M of integration costs. This is expected and acceptable as long as Year 2–3 shows a credible path to accretion. Sophisticated investors look through Year 1 noise.
The $155M incremental interest represents approximately 7.0% blended average rate on $2,222M of new debt: Term Loan ($1,000M × ~5.5%) = $55M plus Senior Notes ($1,222M × ~8.2%) = $100M. Real models also build in debt amortization schedules and track the changing debt balance each year.
| Item | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Standalone Acquirer EPS | $1.364 | $1.500 | $1.650 |
| After-Tax Synergies | +$0.178 | +$0.444 | +$0.681 |
| After-Tax Integration Costs | −$0.282 | −$0.163 | −$0.089 |
| After-Tax Incremental Interest | −$0.461 | −$0.437 | −$0.409 |
| Incremental D&A (after-tax) | −$0.104 | −$0.104 | −$0.104 |
| Target Standalone Contribution | +$0.363 | +$0.380 | +$0.400 |
| Pro Forma EPS | $1.058 | $1.520 | $2.129 |
| Accretion / (Dilution) vs. Standalone | (22.4%) | +1.3% | +28.9% |
The deal reaches EPS neutrality in Year 2 and becomes meaningfully accretive in Year 3, once the full synergy ramp is realized and integration costs have faded. This is the standard "J-curve" pattern in industrial M&A: pain upfront, gain over time. A well-structured bank book will present this trajectory explicitly.
| Metric | Pre-Deal | Pro Forma (No Syns) | Pro Forma (With Syns) |
|---|---|---|---|
| Total Gross Debt | $2,500M | $4,422M | $4,422M |
| Cash | $600M | $200M | $200M |
| Net Debt | $1,900M | $4,222M | $4,222M |
| Pro Forma EBITDA (Year 1) | $800M | $1,000M | $1,060M |
| Net Debt / EBITDA | 2.4x | 4.2x | 3.9x |
| EBIT / Interest Expense | 4.6x | 2.5x | 2.6x |
| FCF / Total Debt | 18% | 9% | 10% |
| Implied Rating (approximate) | BBB | BB+ / BB | BB+ |
The leverage jump from 2.4x to 4.2x net debt/EBITDA is likely to push the acquirer from investment-grade (BBB) to high-yield territory (BB/BB+). This is a significant consequence: high-yield issuers face higher borrowing costs, more restrictive covenants, and a smaller investor base. Management would typically commit to a deleveraging plan (target ≤3.0x by Year 3) to reassure ratings agencies.
What goes in the "Uses" column of a sources and uses table?
Answer: Three categories. (1) Equity purchase price — the total consideration paid to target shareholders. (2) Debt refinancing — any target debt that gets repaid at close due to change-of-control provisions. (3) Transaction fees — banker advisory fees, legal, accounting, and financing fees. Total uses must equal total sources. Forgetting transaction fees is a common mistake that throws off the model.
Why does goodwill increase when you acquire a company at a premium to book value?
Answer: When the purchase price exceeds the fair value of the target's identifiable net assets (assets minus liabilities, marked to fair value), the excess is goodwill. Goodwill represents the premium paid for unidentifiable assets — brand, customer relationships, workforce, synergies, going-concern value. Under US GAAP, goodwill is not amortized but is tested annually for impairment. If the acquisition underperforms, goodwill can be impaired (written down), creating a non-cash charge that hits the income statement.
How does a PP&E write-up in a purchase price allocation affect the income statement?
Answer: When PP&E is written up to fair value in the PPA, the higher asset value generates higher depreciation going forward. This incremental D&A reduces pro forma EBIT and net income, making the deal more dilutive on an EPS basis. The effect is a real income statement hit, even though it's non-cash. Analysts sometimes add back PPA-related D&A to get a "cash EPS" figure that strips out this accounting adjustment.
Why do analysts discount revenue synergies more than cost synergies?
Answer: Cost synergies are largely within management's control — you can decide to close a plant, cut headcount, or renegotiate procurement contracts. The timing and magnitude are reasonably predictable. Revenue synergies depend on customer behavior: will the combined sales force actually cross-sell effectively? Will customers buy the new product? These outcomes depend on external parties and are far more uncertain. As a result, rating agencies, equity analysts, and skeptical buyers haircut revenue synergies heavily and often assign them no value in initial valuation work.